115 results
Page 4 of 6
8-K
EX-99.1
c4ayay2 6q8s5km
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am
8-K
EX-1.1
dqe6ujn6tsr 981mt5wb
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
w9avz6t00nbq57sg
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
rem zimjehafq
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
li0oa16l821 jfv1
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
1wdu efe8i3qiw3v9x6
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
424B5
589mpujj2gwx 2livi
9 Nov 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
2ugllv2
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
8-K
4g4q 7blfqsj0
5 Apr 21
Departure of Directors or Certain Officers
4:49pm